Texas Biomed at forefront of Sudan ebolavirus biomedical R&D

A Sudan ebolavirus vaccine and antibody therapeutic tested at Texas Biomedical Research Institute have been sent to Uganda as part of efforts to control the out

Related Keywords

Sudan ,Uganda ,Texas ,United States ,The Sudan ,Ugandan ,Ricardo Carrion Jr ,Kendra Alfson ,Cory Hallam ,National Primate Research Center ,Texas Biomedical Research Institute ,Biomedical Advanced Research ,Texas Biomed Maximum Containment Contract Research ,Us Department Of Health ,Human Services ,World Health Organization ,Administration For Strategic Preparedness ,Mapp Biopharmaceutical Inc ,Development Authority ,Sabin Vaccine Institute ,Business Development ,Texas Biomed ,Mapp Biopharmaceutical ,Strategic Preparedness ,Vice President ,Ricardo Carrion ,Maximum Containment Contract Research ,Southwest National Primate Research Center ,Texas Biomed Staff Scientist Kendra Alfson ,Newswise ,Udan Ebola Virus Sudan Ebolavirus Uganda Vaccine Antibody Cocktails Therapeutic Animal Model ,Infectious Diseases ,Public Health ,Vaccines ,Ebola ,Pharmaceuticals ,All Journal News ,Grant Funded News ,